FELUDA, India’s first CRISPR COVID-19 test, gets regulator’s nod A joint effort of the Tata Group and CSIR-IGIB, FELUDA moved from R&D to a high-accuracy, scalable and reliable test in less…
FELUDA aims to provide an economical, accurate and easy-to-perform assay on COVID-19 CSIR’s constituent lab, Institute of Genomics and Integrative Biology (CSIR-IGIB) have recently invented FELUDA, designed for…
